Efficacy and Safety of 5-Day Oral Ensitrelvir in the Treatment of Patients With Mild to Moderate COVID-19
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
JAMA Network Open
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Efficacy and Safety of 5-Day Oral Ensitrelvir for Patients With Mild to Moderate COVID-19: The SCORPIO-SR Randomized Clinical Trial
JAMA Netw Open 2024 Feb 05;7(2)e2354991, H Yotsuyanagi, N Ohmagari, Y Doi, M Yamato, NH Bac, BK Cha, T Imamura, T Sonoyama, G Ichihashi, T Sanaki, Y Tsuge, T Uehara, H MukaeFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.